Jeff Yass’s Regencell Bioscience RGC Stock Holding History
Bought
Maintained
Sold
Other funds holding RGC
Jeff Yass's RGC Position: Q3 2026 in Review
Jeff Yass increased its Regencell Bioscience (RGC) stake by 86% in Q3 2026, buying an estimated $115K and bringing the position to 43,075 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #11236.
Jeff Yass first reported a position in RGC in Q2 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.
- Jeff Yass held 43,075 shares of Regencell Bioscience worth $268K as of Q3 2026.
- Jeff Yass bought 19,946 Regencell Bioscience shares in Q3 2026, an estimated $115K.
- Regencell Bioscience made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11236 holding.
- Jeff Yass first reported a position in Regencell Bioscience in Q2 2026 and has held it in 2 quarters since.
- 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.